Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Taylor

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
The American Journal of Psychiatry|June 4, 2002
Prolongation of QTc interval and antipsychoticsDavid M Taylor
British Medical Bulletin|October 3, 2003
Preventing accidental transmission of human transmissible spongifom encephalopathiesDavid M Taylor
CNS Drugs|March 5, 2017
Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?David M Taylor
Radiation Protection Dosimetry|June 8, 2007
Assessment of contributors to radiation dose following intakes of rapidly excreted [14C]-compoundsDavid M Taylor
Radiation Protection Dosimetry|March 20, 2004
Biokinetic models for the behaviour of carbon-14 from labelled compounds in the human body: can a single generic model be justified?David M Taylor
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 10, 2002
A moral and legal obligationDavid M Taylor
Radiation Protection Dosimetry|September 18, 2007
Radiation doses from some [3H]-labelled organic compounds following ingestionDavid M Taylor
CNS Drugs|June 7, 2012
Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?Azizah Attard, David M Taylor
Nordic Journal of Psychiatry|January 29, 2019
Ethnopharmacology<sup>†</sup>David M Taylor, Ursula Werneke
Nordic Journal of Psychiatry|January 29, 2019
Reducing the stigma of long acting injectable antipsychotics - current concepts and future developmentsDavid M Taylor, Sitaram Velaga, Ursula Werneke
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
The American Journal of Psychiatry|June 4, 2002
Prolongation of QTc interval and antipsychoticsDavid M Taylor
British Medical Bulletin|October 3, 2003
Preventing accidental transmission of human transmissible spongifom encephalopathiesDavid M Taylor
CNS Drugs|March 5, 2017
Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?David M Taylor
Radiation Protection Dosimetry|June 8, 2007
Assessment of contributors to radiation dose following intakes of rapidly excreted [14C]-compoundsDavid M Taylor
Radiation Protection Dosimetry|March 20, 2004
Biokinetic models for the behaviour of carbon-14 from labelled compounds in the human body: can a single generic model be justified?David M Taylor
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 10, 2002
A moral and legal obligationDavid M Taylor
Radiation Protection Dosimetry|September 18, 2007
Radiation doses from some [3H]-labelled organic compounds following ingestionDavid M Taylor
CNS Drugs|June 7, 2012
Comparative effectiveness of atypical antipsychotics in schizophrenia: what have real-world trials taught us?Azizah Attard, David M Taylor
Nordic Journal of Psychiatry|January 29, 2019
Ethnopharmacology<sup>†</sup>David M Taylor, Ursula Werneke
Nordic Journal of Psychiatry|January 29, 2019
Reducing the stigma of long acting injectable antipsychotics - current concepts and future developmentsDavid M Taylor, Sitaram Velaga, Ursula Werneke
Pageof 10